Top Markets
#1 Akedo Akedo +59.38%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.41%
#4 Velvet Velvet +39.92%
#5 Black Phoenix Black Phoenix +34.56%
#6 Ο„emplar Ο„emplar +23.53%
#7 Ribbita by Virtuals Ribbita by Virtuals +17.77%
#8 Cross Cross +15.77%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.57%
#10 Bitway Bitway +15.46%
Coin of the day
Akedo Akedo
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Entheon Biomedical Corp. Entheon Biomedical Corp.

Entheon Biomedical Corp.

ENBI
Kedudukan dalam Saham #38407
Entheon Biomedical Corp. functions as a biotechnology firm focused on the... Entheon Biomedical Corp. functions as a biotechnology firm focused on the research and development of novel pharmaceuticals. The company is actively involved in pioneering and introducing to market psychedelic therapeutic products, specifically those derived from N,N-dimethyltryptamine (DMT), with the aim of combating addiction and various substance use disorders. Its services are provided to medical doctors, healthcare facilities, and accredited psychiatrists across Canada, the United States, and the European Union. Entheon Biomedical Corp.'s primary operations are based in Vancouver, Canada.
Harga Saham
$0.0719818
Disegerakkan terakhir: 2026-01-15
Modal Pasaran
$997.59K
Perubahan (1 hari)
-0.09%
Perubahan (1 tahun)
4.67%
Negara
CA
Perdagangan Entheon Biomedical Corp. (ENBI)

Kategori

Healthcare
Pendapatan untuk Entheon Biomedical Corp. (ENBI)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Entheon Biomedical Corp., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Entheon Biomedical Corp. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE